Neoadjuvant Chemotherapy
Showing 26 - 50 of >10,000
Breast Cancer, HER2-positive Breast Cancer Trial in São Paulo (PHESGO)
Not yet recruiting
- Breast Cancer
- HER2-positive Breast Cancer
-
São Paulo, BrazilCentro Paulista de Oncologia (Oncoclínicas)
Oct 3, 2023
Neoadjuvant Chemotherapy in Upper Tract Urothelial Carcinoma
Not yet recruiting
- Upper Excretory Tract Tumors
- Patients with Upper excretory tract tumors
- (no location specified)
Jan 3, 2023
Gastric Cancer Trial in Shijiazhuang (Robot-assisted D2 distal gastrectomy)
Recruiting
- Gastric Cancer
- Robot-assisted D2 distal gastrectomy
-
Shijiazhuang, Hebei, ChinaFourth Affiliated Hospital of Hebei Medical University
Feb 5, 2023
Esophageal Cancer Trial in Moscow (Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.,
Recruiting
- Esophageal Cancer
- Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.
- Patients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomy
-
Moscow, Russian FederationN.N. Blokhin National Medical Research Center of Oncology
Oct 2, 2022
DLCS for Predicting Neoadjuvant Chemotherapy Response
Recruiting
- Gastric Cancer
- +4 more
- develop and visualized a radio-clinical signatures from pretreatment oversampled CT images
-
Hangzhou, Zhejiang, ChinaCancer Hospital of the University of Chinese Academy of Sciences
Nov 8, 2022
Axillary Nodal Status After Neoadjuvant Chemotherapy in Breast
Active, not recruiting
- Breast Cancer
-
Pavia, Lombardia, ItalyIstituti Clinici Scientifici Maugeri SpA
Mar 22, 2023
Breast Cancer Trial in Dallas (Digital Mammography, Low Osmolar Contrast Material, 300-399 Mg/Ml Iodine Concentration, Per Ml)
Active, not recruiting
- Breast Cancer
- Digital Mammography
- Low Osmolar Contrast Material, 300-399 Mg/Ml Iodine Concentration, Per Ml
-
Dallas, TexasUT Southwestern Medical Center
Jan 2, 2023
Gastric Cancer Trial in Fuzhou (response to neoadjuvant chemo)
Completed
- Gastric Cancer
- response to neoadjuvant chemotherapy
-
Fuzhou, Fujian, ChinaDepartment of Gastric Surgery
Jul 15, 2022
Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in
Not yet recruiting
- Pancreas Adenocarcinoma
- +2 more
- Nab paclitaxel
- +3 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023
Breast Cancer, Radiotherapy Trial in Bologna (SBRT anticipated boost)
Recruiting
- Breast Cancer
- Radiotherapy
- SBRT anticipated boost
-
Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna
Jan 9, 2023
Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)
Recruiting
- Gastric Cancer
- +10 more
- Docetaxel
- +3 more
-
Kyiv, UkraineNational Cancer Institute
Aug 31, 2023
Muscle-Invasive Bladder Carcinoma, Chemo Effect, Surgery Trial in Rome (cisplatin based neoadjuvant chemo, Radical cystectomy
Recruiting
- Muscle-Invasive Bladder Carcinoma
- +2 more
- cisplatin based neoadjuvant chemotherapy
- Radical cystectomy alone
-
Rome, ItalyRiccardo Mastroianni
Mar 8, 2023
Triple Negative Breast Cancer Trial in Dhaka (Doxorubicin, Cyclophosphamide, Paclitaxel)
Not yet recruiting
- Triple Negative Breast Cancer
- Doxorubicin
- +3 more
-
Dhaka, BangladeshBangabandhu Sheikh Mujib Medical University
May 24, 2023
Cell-in-cell Structure in Breast Cancer Undergoing Neoadjuvant
Recruiting
- Breast Neoplasms
- Neoadjuvant therapy
-
Beijing, Beijing, ChinaBeijing Shijitan Hospital, Capital Medical University
Dec 6, 2022
Gastric Cancer Trial in Shanghai (68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT)
Recruiting
- Gastric Cancer
- 68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT
-
Shanghai, Shanghai, ChinaShanghai Ruijin Hospital
Dec 2, 2022
Breast Cancer Trial in Naestved (Prehabilitation program)
Recruiting
- Breast Cancer
- Prehabilitation program
-
Naestved, DenmarkDepartment of Clinical Oncology and Palliative Care, Zealand Uni
Jan 31, 2023
Breast Cancer Trial in Paris (Activity tracker)
Recruiting
- Breast Cancer
- Activity tracker
-
Paris, France
- +2 more
Dec 13, 2022
Breast Cancer Trial in Istanbul (Carbon Black Tattoo)
Recruiting
- Breast Cancer
- Carbon Black Tattoo
-
Istanbul, TurkeyGaziosmanpasa Training and Research Hospital
Feb 17, 2023
Breast Cancer Trial in New York (Harmonic motion imaging)
Recruiting
- Breast Cancer
- Harmonic motion imaging
-
New York, New YorkColumbia University Irving Medical Center/NYP
Nov 7, 2022
Gastric Cancer, Neoadjuvant Chemo Trial in Qingdao (live combined Bifidobacteriun, Lactobacillus and Enterococcus capsules)
Recruiting
- Gastric Cancer
- Neoadjuvant Chemotherapy
- live combined Bifidobacteriun, Lactobacillus and Enterococcus capsules
-
Qingdao, Shandong, ChinaDepartment of Gastrointestinal Surgery, Qingdao University Affil
Jun 4, 2023
ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.
Recruiting
- Breast Cancer Female
- +4 more
-
Ho Chi Minh City, Vietnam
- +1 more
Oct 16, 2023
Chemoresistance Mechanisms in Pancreatic Cancer
Not yet recruiting
- Patients With Non-metastatic Pancreatic Cancer
- Evaluation of Tumor Resectability Shall be Made in Consensus at Multidisciplinary Meetings, According to NCCN Guideline Version 1.2022 Pancreatic Adenocarcinoma
- ctDNA detection
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Apr 27, 2023
Neoadjuvant Chemotherapy Compared With Surgery for Esophageal
Completed
- Esophagus Cancer
- Paclitaxel- and platinum-based chemotherapy
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzh
Oct 5, 2022
Gastric Cancer Trial in Shanghai (camrelizumab+chemo, Chemotherapy)
Recruiting
- Gastric Cancer
-
Shanghai, Shanghai, ChinaRuijin Hospital
Aug 9, 2022